<sup>177</sup>Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-Label, Randomized, Controlled, Phase II Study. [PDF]
Kishan AU +30 more
europepmc +1 more source
Stereotactic ablative radiotherapy (SABR) for pelvic nodal oligorecurrence in prostate cancer. [PDF]
Lopez-Valcarcel M +15 more
europepmc +1 more source
The Landscape of Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Cancer (RCC). [PDF]
Moreno-Olmedo E +6 more
europepmc +1 more source
Stereotactic ablative radiotherapy: a game-changer in primary renal cancer therapy. [PDF]
Castronovo FM +3 more
europepmc +1 more source
Adrenal Insufficiency following Stereotactic Ablative Radiotherapy (SAbR) of Adrenal Gland Metastases. [PDF]
Hamidi O +10 more
europepmc +1 more source
The potential of integrating stereotactic ablative radiotherapy techniques with hyperfractionation for lung cancer. [PDF]
Chiou CC +7 more
europepmc +1 more source
Accelerated hypofractionated chemoradiation followed by stereotactic ablative radiotherapy boost for locally advanced, unresectable non-small cell lung cancer. [PDF]
Weber UM +3 more
europepmc +1 more source
Efficacy of a thermoplastic mask and pneumatic abdominal compression device for immobilization in stereotactic ablative radiotherapy of spine metastases. [PDF]
Walter YA +4 more
europepmc +1 more source
Robotic Stereotactic Ablative Radiotherapy for Patients with Early-Stage Lung Cancer: Results of an Interim Analysis. [PDF]
Zygogianni A +9 more
europepmc +1 more source
Comparative analysis of delivered and planned doses in target volumes for lung stereotactic ablative radiotherapy. [PDF]
Yu GB +5 more
europepmc +1 more source

